NCT05864885View on ClinicalTrials.gov

Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

PHASE1UnknownINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 9, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Androgenetic Alopecia
Interventions
DRUG

Minoxidil

Topical formulation applied once a day.

Sponsors
All Listed Sponsors
collaborator

DataPharm Australia, CMAX Clinical Research, Agilex Australia

UNKNOWN

lead

Aneira Pharma, Inc.

INDUSTRY

NCT05864885 - Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia | Biotech Hunter | Biotech Hunter